Navigating the COVID-19 Vaccine Response

This chapter examines the mixed outcomes of the COVID-19 vaccine rollout, critiquing the FDA's slow approval processes and the accompanying bureaucratic challenges. It discusses the implications of these delays on public perception and vaccine distribution, while highlighting missed opportunities for quicker action in combating the pandemic.